References
- Tremblay RR, Morales A. Canadian practice recommendations for screening, monitoring and treating men affected by andropause or partial androgen deficiency. Aging Male 1998;1:213–18
- Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen defi-ciency in aging males. Metabolism 2000;49:1239–42
- Morales A, Johnston B, Heaton JP, Lundie M. Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes. J Urol 1997;157:849–54
- Vermeulen A. Androgens in the aging male. J Clin Endocrinol Metab 1991;73:221–4
- Morley JE, Kaiser FE, Perry HM III, et al. Longitu-dinal changes in testosterone, LH, and FSH in healthy older men. Metabolism 1997;46:410–13
- Bremner WJ, Witiello V, Prinz PN. Loss of circa-dian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab 1983;56:1278–81
- Harman SM, Tsitouras PD. Reproductive hor-mones in aging men. I. Measurement of sex steroids, basal luteinizing hormone, and leydig cell response to human chorionic gonadotropin. J Clin Endocrinol Metab 1980;51:35–50
- Bhasin S. Androgen treatment of hypogonadal men. J Clin Endocrinol Metab 1992;74:1221–5
- Davidson JM, Chen JJ, Crapo L, et al. Hormonal changes and sexual function in aging men. J Clin Endocrinol Metab 1983;57:71–7
- Kwan M, Greenleaf WJ, Mann J, et al. The nature of androgen action on male sexuality: a combined laboratory-self report study in hypogonadal men. J Clin Endocrinol Metab 1983;57:557–62
- Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychological correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54–61
- Morales A, Carson CC, Heaton J. Aging male: post-graduate course (H0030 PG). Baltimore, MD: American Urological Association, 2001